HET REGIMEN (TRASTUZUMAB, EPIRUBICIN ANDTAXOTERE) AS A FIRST LINE TREATMENT IN METASTATIC BREAST CANCER. A MULTICENTER PHASE II STUDY


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles